Supernus Pharmaceuticals Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$211,572	$192,103	$165,453	$149,824
Gross Profit	188,565	143,772	148,626	134,061
EBITDA	90,261	-36,596	33,499	17,787
EBIT	-1,914	-57,954	12,141	-2,596
Net Income	-4,105	-45,117	22,499	-11,827
Net Change In Cash	211,572	192,103	165,453	149,824
Free Cash Flow	19,434	-61,793	58,080	30,272
Cash	128,448	151,371	144,711	115,848
Basic Shares	57,344	56,552	56,643	55,864

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$718,952	$661,817	$607,521	$667,238
Gross Profit	644,390	583,911	523,742	580,017
EBITDA	41,004	178,284	90,043	153,356
EBIT	-49,030	97,870	5,184	67,813
Net Income	-38,550	73,865	1,316	60,711
Net Change In Cash	718,952	661,817	607,521	667,238
Cost of Revenue				-110,314
Free Cash Flow	45,993	171,226	110,534	116,414
Cash	128,448	69,331	75,054	93,120
Basic Shares	56,451	55,959	55,506	61,679